Liqiang Xi
0000-0001-5033-7072
National Institutes of Health
5 papers found
Refreshing results…
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy
Recurrent somatic JAK3 mutations in NK-cell enteropathy
Missing publications? Search for publications with a matching author name.